CVS Health Corporation (CVS)

Market Cap	134.72B
Revenue (ttm)	315.23B
Net Income (ttm)	3.15B
Shares Out	1.32B
EPS (ttm)	2.37
PE Ratio	42.89
Forward PE	11.60
Dividend	$2.20 (2.16%)
Ex-Dividend Date	Oct 20, 2022

Volume	3,785,717
Open	102.17
Previous Close	102.53
Day's Range	101.53 - 102.69
52-Week Range	86.28 - 111.25
Beta	0.68
Analysts	Buy
Price Target	120.17 (+18.2%)
Earnings Date	Nov 2, 2022

About CVS

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary mana...

• Industry: Health Care Providers & Services
• Founded: 1963
• CEO: Larry Merlo
• Employees: 216,000
• Stock Exchange: NYSE
• Ticker Symbol: CVS

Financial Performance

In 2021, CVS Health's revenue was $292.11 billion, an increase of 8.71% compared to the previous year's $268.71 billion. Earnings were $7.91 billion, an increase of 10.18%.

Analyst Forecast

According to 32 analysts, the average rating for CVS stock is "Buy." The 12-month stock price forecast is 120.17, which is an increase of 18.22% from the latest price.

Price Target

$120.17

(18.22% upside)

Analyst Consensus: Buy